AMR testing technology from QuantaMatrix backed by research paper in Nature dlvr.it/TCBGTB #News #AMR #Antimicrobialresistance

SynaptixBio awarded £2m BioMedical Catalyst grant from Innovate UK dlvr.it/TCDnHV #News #BioMedicalCatalystgrant #innovateUK

New drug trial to investigate treatment for patients with bronchiectasis dlvr.it/TCDnK9 #News #AIRNE #AIRNET

Association for Medical Education in Europe AMEE 2024 conference dlvr.it/TCH53W #News #AMEE2024 #AssociationforMedicalEducationinEurope

MHRA approves Astellas’ Vyloy combination for gastric cancer dlvr.it/TCH54m #News #Astellas #gastriccancer

Improving tracking of AMR bacteria in hospitals using new genomic technique dlvr.it/TCQv6q #News #AMR #Antimicrobialresistance

National campaign launches to end prostate cancer postcode lottery dlvr.it/TCR30l #News #oncology #ProactiveForYourProstate

A new dawn has broken (has it not?) dlvr.it/TCTJCR #WebExclusives

myTomorrows and Pancreatic Cancer Europe partner on clinical trials dlvr.it/TCTL4d #News #myTomorrows #oncology

Acelyrin’s izokibep for hidradenitis suppurativa reveals positive results dlvr.it/TCTLYv #News #Acelyrin #dermatology

Steve Hopkinson dlvr.it/TCjW5k #Appointments

James Halle dlvr.it/TCjWTB #Appointments

Geoffrey Hodge dlvr.it/TCllwQ #Appointments

Adam Rosenberg dlvr.it/TClrDs #Appointments

Dr Jonathan Appleby dlvr.it/TCpHrw #Appointments

Simon Jones  dlvr.it/TCpHv2 #Appointments

European Commission grants orphan drug designation for Vivet’s VTX-806 dlvr.it/TCrfyZ #News

AMBLor prognostic melanoma biomarker receives UKCA Mark dlvr.it/TCrj4s #News

Eli Lilly’s once-weekly insulin shows promise in phase 3 trials dlvr.it/TCvXLf #News

Cloud moment dlvr.it/TCvYKy #ThoughtLeadership